Global mRNA Vaccine And Therapeutics Market Report By End-User (Infectious Disease, Cancer And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210485
February 2020
Report Formats:

As per this study, the Global mRNA Vaccine And Therapeutics Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines. These are gaining high importance to reduce the incidence of cancer and infectious diseases like measles, smallpox and a wide range of pathogens such as Ebola, influenza, HIV, etc.
 
Market Dynamics
 
Rising adoption of mRNA vaccine owing to its higher efficiency and shorter manufacturing times is driving the market growth. Rising licensing agreements between mRNA vaccine manufacturers, and prominent vaccine developers’ to offer advanced infectious disease vaccination is further boosting the market demand. Additionally, the excellent ability of mRNA to combine multiple molecules into a single therapeutic has gained significant attention from potential investors and the pharmaceutical industry, is again contributing the market growth. Challenges regarding unintended side effects may act as a restraint of market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of mRNA vaccine and therapeutics.
 
Market Segmentation
 
The broad mRNA vaccine and therapeutics market has been sub-grouped into end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By End-User

  • Infectious Disease
  • Cancer
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for mRNA vaccine and therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on the demand for individual application segments in all the regions.
 
Europe mRNA Vaccine And Therapeutics Market By Revenue (USD MN)
 

 
The report also covers a detailed competitive landscape including company profiles of key players operating in the global market. The key players in the mRNA vaccine and therapeutics market include Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology and Translate Bio. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Mrna Vaccine And Therapeutics Market
       2.2. Global Mrna Vaccine And Therapeutics Market Snapshot
 
3 . MRNA VACCINE AND THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Mrna Vaccine And Therapeutics Market
       3.3. Market Restraints of Mrna Vaccine And Therapeutics Market
       3.4. Opportunities of Mrna Vaccine And Therapeutics Market
       3.5. Trends of Mrna Vaccine And Therapeutics Market
       3.6. Porter’s Five Force Analysis of Mrna Vaccine And Therapeutics Market
       3.7. Mrna Vaccine And Therapeutics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by End-User
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Mrna Vaccine And Therapeutics Value Chain Analysis
       4.2. Mrna Vaccine And Therapeutics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Mrna Vaccine And Therapeutics Raw Material Manufactures List
           4.2.3. Price Trend of Mrna Vaccine And Therapeutics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET ANALYSIS BY END-USER
       5.1 Overview by End-User
       5.2 Global Mrna Vaccine And Therapeutics Market Analysis by End-User
       5.3 Market Analysis of Infectious Disease by Regions
       5.4 Market Analysis of Cancer by Regions
       5.5 Market Analysis of Others by Regions
 
6 . GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       6.1. Regional Outlook
       6.2. Introduction
       6.3. North America
           6.3.1. Overview
           6.3.2. North America Mrna Vaccine And Therapeutics Market Estimate by Market Segment
           6.3.3. North America Mrna Vaccine And Therapeutics Market Estimate by Country
           6.3.4. United State
           6.3.5. Rest of North America
       6.4. Europe
           6.4.1. Overview
           6.4.2. Europe Mrna Vaccine And Therapeutics Market Estimate by Market Segment
           6.4.3. Europe Mrna Vaccine And Therapeutics Market Estimate by Country
           6.4.4. United Kingdom
           6.4.5. France
           6.4.6. Germany
           6.4.6 Rest of Europe
       6.5. Asia Pacific
           6.5.1. Overview
           6.5.2. Asia Pacific Mrna Vaccine And Therapeutics Market Estimate by Market Segment
           6.5.3. Asia Pacific Mrna Vaccine And Therapeutics Market Estimate by Country
           6.5.4. China
           6.5.5. Japan
           6.5.6. India
           6.5.6. Rest of Asia Pacific
       6.6. Latin America
           6.6.1. Overview
           6.6.2. Latin America Mrna Vaccine And Therapeutics Market Estimate by Market Segment
           6.6.3. Latin America Mrna Vaccine And Therapeutics Market Estimate by Country
           6.6.4. Brazil
           6.6.5. Rest of Latin America
       6.7. Middle East & Africa
           6.7.1. Overview
           6.7.2. Middle East & Africa Mrna Vaccine And Therapeutics Market Estimate by Market Segment
           6.7.3. Middle East & Africa Mrna Vaccine And Therapeutics Market Estimate by Country
           6.7.4. Middle East
           6.7.5. Africa
 
7 . COMPETITIVE LANDSCAPE OF THE MRNA VACCINE AND THERAPEUTICS COMPANIES
       7.1. Mrna Vaccine And Therapeutics Market Competition
       7.2. Partnership/Collaboration/Agreement
       7.3. Merger And Acquisitions
       7.4. New Product Launch
       7.5. Other Developments
 
8 . COMPANY PROFILES OF MRNA VACCINE AND THERAPEUTICS INDUSTRY
       8.1. Company Share Analysis
       8.2. Market Concentration Rate
       8.3. Argos Therapeutics
           8.3.1. Company Overview
           8.3.2. Financials
           8.3.3. Products
           8.3.4. Recent Developments
       8.4. BioNTech
           8.4.1. Company Overview
           8.4.2. Financials
           8.4.3. Products
           8.4.4. Recent Developments
       8.5. CureVac
           8.5.1. Company Overview
           8.5.2. Financials
           8.5.3. Products
           8.5.4. Recent Developments
       8.6. eTheRNA
           8.6.1. Company Overview
           8.6.2. Financials
           8.6.3. Products
           8.6.4. Recent Developments
       8.7. Ethris
           8.7.1. Company Overview
           8.7.2. Financials
           8.7.3. Products
           8.7.4. Recent Developments
       8.8. In-Cell-Art
           8.8.1. Company Overview
           8.8.2. Financials
           8.8.3. Products
           8.8.4. Recent Developments
       8.9. Moderna Therapeutics
           8.9.1. Company Overview
           8.9.2. Financials
           8.9.3. Products
           8.9.4. Recent Developments
       8.10. Sangamo Therapeutics
           8.10.1. Company Overview
           8.10.2. Financials
           8.10.3. Products
           8.10.4. Recent Developments
       8.11. Tiba Biotechnology
           8.11.1. Company Overview
           8.11.2. Financials
           8.11.3. Products
           8.11.4. Recent Developments
       8.12. Translate Bio
           8.12.1. Company Overview
           8.12.2. Financials
           8.12.3. Products
           8.12.4. Recent Developments
 
 9.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       9.1. Impact Analysis of Covid-19 Outbreak on the Market
           9.1.1. Direct Impact on Production
           9.1.2. Supply Chain and Market Disruption
           9.1.3. Financial Impact on Firms and Financial Markets
       9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       9.3. Pre V/S Post COVID-19 Market
       9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       9.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  •  Global Market Snapshot
  •  Drivers of the Global Market Impact Analysis
  •  Restraints of the Global Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers 
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19 Market
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  •  COVID-19: Micro and Macro Factor Analysis on the Market
  •  Global Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Infectious Disease by Geography (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Cancer by Geography (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market by Geography (USD MN)
  •  North America Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  North America Mrna Vaccine And Therapeutics Market Estimate by Country (USD MN)
  •  United State Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Rest of North America Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Europe Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  United Kingdom Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  France Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Germany Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Rest of Europe Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Asia Pacific Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Asia Pacific Mrna Vaccine And Therapeutics Market Estimate by Country (USD MN)
  •  China Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Japan Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  India Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Rest of Asia Pacific Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Latin America Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Latin America Mrna Vaccine And Therapeutics Market Estimate by Country (USD MN)
  •  Brazil Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Rest of Latin America Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Middle East & Africa Mrna Vaccine And Therapeutics Market Estimate by End-User (USD MN)
  •  Middle East & Africa Mrna Vaccine And Therapeutics Market Estimate by Country (USD MN)
  •  Middle East Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Africa Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Mrna Vaccine And Therapeutics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Mrna Vaccine And Therapeutics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by End-User
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Mrna Vaccine And Therapeutics Market Analysis by End-User (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Infectious Disease by Geography (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Cancer by Geography (USD MN)
  •  Global Mrna Vaccine And Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Latin America Mrna Vaccine And Therapeutics Market by Revenue
  •  Middle East & Africa Mrna Vaccine And Therapeutics Market by Revenue
  •  Recent Development in Mrna Vaccine And Therapeutics Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials